SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-20-000039
Filing Date
2020-04-24
Accepted
2020-04-23 20:00:54
Documents
16
Period of Report
2020-04-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x04x24pressrel.htm   iXBRL 8-K 46051
2 EXHIBIT 99 ebs-2020x04x24prexhibi.htm EX-99 20139
8 a042320johnsonjohnson_image1.jpg GRAPHIC 117423
  Complete submission text file 0001367644-20-000039.txt   376327

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20201231.xsd EX-101.SCH 4492
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20201231_cal.xml EX-101.CAL 662
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20201231_def.xml EX-101.DEF 1512
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20201231_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20201231_pre.xml EX-101.PRE 14152
10 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x04x24pressrel_htm.xml XML 4390
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 20812233
SIC: 2834 Pharmaceutical Preparations